Daniel Meyersfeld
Chairman
Molecular Biology
DNALYSIS Biotechnology
South Africa
Biography
Dr. Daniel Meyersfeld completed his PhD in molecular biology from the University of the Witwatersrand, South Africa, in 2005. During his studies, he saw an opportunity to use recent advances in the field of human genetics to improve people’s health and wellness and he established DNAlysis Biotechnology in 2007 to bring the benefits of these advances to the South African health and wellness markets. The company is now recognized as a global leader in the field of biotechnology, with an established practitioner following in South Africa, Scandinavia, Europe, Far East, Middle East and the USA.
Research Interest
Molecular Biology
